Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Travere Therapeutics (TVTX)
NASDAQ:TVTX
Holding TVTX?
Track your performance easily
See the Price Targets and Ratings of:
TVTX Analyst Ratings
Strong Buy
13 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TVTX Stock 12 Month Forecast
Average Price Target
$26.50
▲(40.88% Upside)
| Highest Price Target$42.00 | Average Price Target$26.50 | Lowest Price Target$15.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
Reiterated
11/19/24
Piper Sandler
Reiterated
11/14/24
TD Cowen
Reiterated
11/05/24
Stifel Nicolaus
Reiterated
11/04/24
Evercore ISI
Reiterated
11/01/24
Bank of America Securities
Assigned
11/01/24
Barclays
Reiterated
11/01/24
Scotiabank
Reiterated
11/01/24
Leerink Partners
Reiterated
10/31/24
Canaccord Genuity
Reiterated
10/31/24
Wells Fargo
$27
Buy
43.54%
Upside
Reiterated
10/27/24
Positive FDA Prospects for Travere Therapeutics Boosts Buy Rating
Guggenheim
$23→$41
Buy
117.97%
Upside
Reiterated
10/09/24
Travere Therapeutics price target raised to $41 from $23 at GuggenheimTravere Therapeutics price target raised to $41 from $23 at Guggenheim
Wedbush
$17→$25
Buy
32.91%
Upside
Reiterated
10/09/24
Wedbush Sticks to Its Buy Rating for Travere Therapeutics (TVTX)
H.C. Wainwright
$23→$18
Buy
-4.31%
Downside
Reiterated
09/27/24
Buy Rating Affirmed for Travere Therapeutics Amid Proactive HARMONY Study Management and Strong Financial Stance
Citi
$23→$19
Buy
1.01%
Upside
Reiterated
09/27/24
Analysts Offer Insights on Healthcare Companies: Adverum Biotechnologies (NASDAQ: ADVM), Biomea Fusion (NASDAQ: BMEA) and Travere Therapeutics (NASDAQ: TVTX)
Best Analysts Covering Travere Therapeutics
Which Analyst Should I Follow If I Want to Buy TVTX and Sell After:
1 Month
xxx
Success Rate
11/15 ratings generated profit
Average Return
+10.03%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 73.33% of your transactions generating a profit, with an average return of +10.03% per trade.
3 Months
xxx
Success Rate
10/15 ratings generated profit
Average Return
+15.70%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +15.70% per trade.
1 Year
Success Rate
16/25 ratings generated profit
Average Return
+22.29%
reiterated a buy rating 2 months ago
Copying Liisa Bayko's trades and holding each position for 1 Year would result in 64.00% of your transactions generating a profit, with an average return of +22.29% per trade.
2 Years
xxx
Success Rate
15/22 ratings generated profit
Average Return
+41.86%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 68.18% of your transactions generating a profit, with an average return of +41.86% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TVTX Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
9
12
20
25
18
Buy
0
2
12
23
24
Hold
4
2
5
8
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
16
37
56
50
Each month's total comprises the sum of three months' worth of ratings.
TVTX Financial Forecast
TVTX Stock Forecast FAQ
What is TVTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Travere Therapeutics’s 12-month average price target is $26.50.
What is TVTX’s upside potential, based on the analysts’ average price target?
Travere Therapeutics has 40.88% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TVTX a Buy, Sell or Hold?
Travere Therapeutics has a consensus rating of Strong Buy which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.
What is Travere Therapeutics’s price target?
The average price target for Travere Therapeutics is $26.50. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $42.00 ,the lowest forecast is $15.00. The average price target represents 40.88% Increase from the current price of $18.81.
The highest analyst price target is $42.00 ,the lowest forecast is $15.00. The average price target represents 40.88% Increase from the current price of $18.81.
What do analysts say about Travere Therapeutics?
Travere Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of TVTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.